NOVA1 and breast carcinoma: In contrast, NOVA1 is considered to be an oncogene and a prognostic factor in multiple malignant tumors, including CRC [35], thyroid cancer [36], breast cancer [37], melanoma [30], osteosarcoma [38], and gastric cancer [31, 39].